(Q35610515)

9 August 2017

1 reference

title

Applications of polymorphisms and pharmacogenomics in obstetrics and gynecology (English)

1 reference

9 August 2017

1 reference

Clemens B Tempfer

1

1 reference

9 August 2017

Christian Schneeberger

series ordinal

2

1 reference

9 August 2017

Johannes C Huber

series ordinal

3

1 reference

9 August 2017

publication date

1 January 2004

1 reference

9 August 2017

1 reference

9 August 2017

volume

5

1 reference

9 August 2017

issue

1

1 reference

9 August 2017

page(s)

57-65

1 reference

Thrombophilic disorders and fetal loss: a meta-analysis

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.57.25687

The classification and definition of the hypertensive disorders of pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.57.25687

A molecular variant of angiotensinogen associated with preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.57.25687

Angiotensinogen: a candidate gene involved in preeclampsia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.57.25687

The factor V Leiden mutation may predispose women to severe preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.57.25687

Evidence for a familial pregnancy-induced hypertension locus in the eNOS-gene region

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.57.25687

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.57.25687

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.57.25687

Hormone replacement therapy, prothrombotic mutations, and the risk of incident nonfatal myocardial infarction in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.57.25687

CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.57.25687

Biological bases of premature ovarian failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.57.25687

The role of genetic factors in age at natural menopause

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.57.25687

Genes control the cessation of a woman's reproductive life: a twin study of hysterectomy and age at menopause

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.57.25687

Inheritance of human breast cancer: evidence for autosomal dominant transmission in high-risk families

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.57.25687

Cytochrome P450 1B1 gene polymorphisms and postmenopausal breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.57.25687

Immunobiology of endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.57.25687

Heritability and molecular genetic studies of endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.57.25687

Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.57.25687

Accessing single nucleotide polymorphisms in genomic DNA by direct multiplex polymerase chain reaction amplification on oligonucleotide microarrays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.57.25687

Effects of estrogen replacement on the progression of coronary-artery atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.57.25687

Tumour necrosis factor-alpha (TNF-alpha) gene polymorphism and expression in pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.57.25687

Association between susceptibility to pre-eclampsia within families and HLA DR4

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.57.25687

Evidence of association of the ecNOS gene polymorphism with plasma NO metabolite levels in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.57.25687

An endothelial nitric oxide synthase gene polymorphism is associated with preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.57.25687

Breast cancer risk associated with CYP1A1 genetic polymorphisms in Japanese women

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.57.25687

Association of CYP1B1 genetic polymorphism with incidence to breast and lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.57.25687

Breast cancer risk associated with polymorphism in CYP19 in Japanese women

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.57.25687

Genetic variants of CYP19 (aromatase) and breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.57.25687

The protective effect of hormone-replacement therapy on fracture risk is modulated by estrogen receptor alpha genotype in early postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.57.25687

Smoking, body mass index, socioeconomic status and the menopausal transition in a British national cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.57.25687

Galactose-1-phosphate uridyl transferase activity associated with age at menopause and reproductive history

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.57.25687

TGFBR1*6A and cancer risk: a meta-analysis of seven case-control studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.57.25687

Estrogen and oncogene mediated growth regulation of human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.57.25687

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.57.25687

Association of estrogen receptor gene polymorphisms with endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.57.25687

Possible involvement of arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1 genes in the development of endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.57.25687

Glutathione S-transferase M1 gene polymorphism and susceptibility to endometriosis in a French population

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.57.25687

10.1517/PHGS.5.1.57.25687

21 January 2018

Identifiers

DOI

1 reference

release_pmqxiyzdyrcstpees55sa5fbci

9 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/pmqxiyzdyrcstpees55sa5fbci

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference